{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T12:10:39Z","timestamp":1737720639979,"version":"3.33.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86846-7","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T11:33:05Z","timestamp":1737718385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLRB1 expression in nasopharyngeal mucosa as a prognostic biomarker in COVID-19 patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Marilina","family":"Garc\u00eda-Aranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Onieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desir\u00e9e","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Padilla-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mart\u00ednez-G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Hortas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garc\u00eda-Galindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Gonz\u00e1lez-Gomariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Arma\u00f1anzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rivas-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Barrag\u00e1n-Mallofret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximino","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"86846_CR1","doi-asserted-by":"crossref","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 323(13): pp. 1239\u20131242. (2020).","DOI":"10.1001\/jama.2020.2648"},{"issue":"5","key":"86846_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respiratory Med. 8 (5), 475\u2013481 (2020).","journal-title":"Lancet Respiratory Med."},{"key":"#cr-split#-86846_CR3.1","unstructured":"Organization, W. H. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. [cited 2023 Jun 18, 2023]"},{"key":"#cr-split#-86846_CR3.2","unstructured":"(2023). Available from: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic"},{"issue":"1","key":"86846_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb, S. et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol. J. 19 (1), 92 (2022).","journal-title":"Virol. J."},{"issue":"9","key":"86846_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson, O. J. et al. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet. Infect. Dis. 22 (9), 1293\u20131302 (2022).","journal-title":"Lancet. Infect. Dis"},{"key":"86846_CR6","doi-asserted-by":"crossref","unstructured":"Tatsis, F. et al. Economic Burden of ICU-Hospitalized COVID-19 patients: A systematic review and Meta-analysis. Cureus 15(7), e41802 (2023).","DOI":"10.7759\/cureus.41802"},{"key":"86846_CR7","doi-asserted-by":"crossref","unstructured":"Rizzi, M. et al. COVID-19 biomarkers at the crossroad between patient stratification and targeted therapy: the role of validated and proposed parameters. Int. J. Mol. Sci., 24(8), 7099 (2023).","DOI":"10.3390\/ijms24087099"},{"key":"86846_CR8","doi-asserted-by":"crossref","unstructured":"Vardavas, C. I. et al. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe. Eur. Respiratory Rev., 31(166), 220098 (2022).","DOI":"10.1183\/16000617.0098-2022"},{"issue":"4","key":"86846_CR9","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/jmv.26699","volume":"93","author":"R Alizadehsani","year":"2021","unstructured":"Alizadehsani, R. et al. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J. Med. Virol. 93(4), 2307\u20132320 (2021).","journal-title":"J. Med. Virol."},{"key":"86846_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s15010-020-01509-1","volume":"49","author":"D Wolff","year":"2021","unstructured":"Wolff, D. et al. Risk factors for Covid-19 severity and fatality: A structured literature review. Infection 49, 15\u201328\/s15010-020-01509 (2021).","journal-title":"Infection"},{"issue":"11","key":"86846_CR11","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.4103\/jfmpc.jfmpc_769_21","volume":"10","author":"J Ranjan","year":"2021","unstructured":"Ranjan, J., Ravindra, A. & Mishra, B. Gender and genetic factors impacting COVID-19 severity. J. Family Med. Prim. Care. 10(11), 3956\u20133963 (2021).","journal-title":"J. Family Med. Prim. Care"},{"issue":"1","key":"86846_CR12","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1038\/s41598-022-09771-z","volume":"12","author":"S Garcia-Guti\u00e9rrez","year":"2022","unstructured":"Garcia-Guti\u00e9rrez, S. et al. Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19. Sci. Rep. 12 (1), 7097 (2022).","journal-title":"Sci. Rep."},{"issue":"9","key":"86846_CR13","first-page":"547","volume":"21","author":"A Flemming","year":"2021","unstructured":"Flemming, A. Poor nasal immunity can lead to severe COVID-19. Nat. Rev. Immunol. 21 (9), 547\u2013547 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"86846_CR14","unstructured":"NanosString Technologies, I.Using the nCounter\u00aeAnalysis System with FFPE Samples for Gene Expression Analysis, inTech Note (2012)."},{"key":"86846_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-9904-0_10","volume-title":"Chimeric RNA: Methods and Protocols","author":"A Goytain","year":"2020","unstructured":"Goytain, A. & Ng, T. NanoString nCounter Technology: High-throughput RNA validation. In Chimeric RNA: Methods and Protocols (eds. Li, H. & Elfman, J.) 125\u2013139 (Springer US, New York, NY, 2020)."},{"issue":"13","key":"86846_CR16","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1158\/0008-5472.CAN-15-0262","volume":"75","author":"MH Veldman-Jones","year":"2015","unstructured":"Veldman-Jones, M. H. et al. Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res. 75 (13), 2587\u20132593 (2015).","journal-title":"Cancer Res."},{"key":"86846_CR17","doi-asserted-by":"publisher","first-page":"p133","DOI":"10.12688\/f1000research.103533.2","volume":"11","author":"M Garc\u00eda Aranda","year":"2022","unstructured":"Garc\u00eda Aranda, M. et al. Laboratory protocol for the digital multiplexed gene expression analysis of nasopharyngeal swab samples using the NanoString nCounter system. F1000Res 11, p133 (2022).","journal-title":"F1000Res"},{"key":"86846_CR18","doi-asserted-by":"crossref","unstructured":"Kashyap, A. et al. Molecular markers for early stratification of disease severity and progression in COVID-19. Biol. Methods Protoc. 7(1), bpac028 (2022).","DOI":"10.1093\/biomethods\/bpac028"},{"issue":"20","key":"86846_CR19","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1182\/bloodadvances.2020002650","volume":"4","author":"M Osman","year":"2020","unstructured":"Osman, M. et al. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19. Blood Adv. 4 (20), 5035\u20135039 (2020).","journal-title":"Blood Adv."},{"issue":"1","key":"86846_CR20","doi-asserted-by":"publisher","first-page":"16814","DOI":"10.1038\/s41598-021-96110-3","volume":"11","author":"MZ Hasan","year":"2021","unstructured":"Hasan, M. Z. et al. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci. Rep. 11 (1), 16814 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"86846_CR21","first-page":"17","volume":"8","author":"DR Sweet","year":"2023","unstructured":"Sweet, D. R., Freeman, M. L. & Zidar, D. A. Immunohematologic biomarkers in COVID-19: insights into Pathogenesis, Prognosis, and Prevention. Pathog Immun. 8 (1), 17\u201350 (2023).","journal-title":"Pathog Immun."},{"issue":"9","key":"86846_CR22","doi-asserted-by":"publisher","first-page":"e3000849","DOI":"10.1371\/journal.pbio.3000849","volume":"18","author":"NA Lieberman","year":"2020","unstructured":"Lieberman, N. A. et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol. 18 (9), e3000849 (2020).","journal-title":"PLoS Biol."},{"key":"86846_CR23","doi-asserted-by":"crossref","unstructured":"Troyano-Hern\u00e1ez, P., Reinosa, R. & Holgu\u00edn, \u00c1. Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in Structural, non-structural, and Accessory proteins. Int. J. Mol. Sci., 23(12), 6394 (2022).","DOI":"10.3390\/ijms23126394"},{"key":"86846_CR24","volume-title":"Patent Application Number P202331044 - KLRB1 como biomarcador de pron\u00f3stico en pacientes con COVID-19 (KLRB1 as prognostic biomarker of COVID-19 patients)","author":"M Garc\u00eda Aranda","year":"2023","unstructured":"Garc\u00eda Aranda, M., Redondo, M., Barrag\u00e1n Mallofret, I. & Mart\u00ednez G\u00e1lvez, B. Patent Application Number P202331044 - KLRB1 como biomarcador de pron\u00f3stico en pacientes con COVID-19 (KLRB1 as Prognostic Biomarker of COVID-19 Patients) (Spain, 2023). O. Madrid, Editor."},{"issue":"1","key":"86846_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1465-9921-12-102","volume":"12","author":"KM Horvath","year":"2011","unstructured":"Horvath, K. M. et al. Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus. Respir. Res. 12 (1), 102 (2011).","journal-title":"Respir. Res."},{"issue":"1","key":"86846_CR26","doi-asserted-by":"publisher","first-page":"15927","DOI":"10.1038\/s41598-021-95532-3","volume":"11","author":"K Winkley","year":"2021","unstructured":"Winkley, K. et al. Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range. Sci. Rep. 11 (1), 15927 (2021).","journal-title":"Sci. Rep."},{"issue":"11","key":"86846_CR27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/genes14112065","volume":"14","author":"EA Ponomarenko","year":"2023","unstructured":"Ponomarenko, E. A. et al. Workability of mRNA sequencing for Predicting protein abundance. Genes 14 (11), 2065 (2023).","journal-title":"Genes"},{"issue":"3","key":"86846_CR28","doi-asserted-by":"publisher","first-page":"e13090","DOI":"10.1111\/sji.13090","volume":"94","author":"\u0141 Wyro\u017cemski","year":"2021","unstructured":"Wyro\u017cemski, \u0141. & Qiao, S. W. Immunobiology and conflicting roles of the human CD161 receptor in T cells. Scand. J. Immunol. 94 (3), e13090 (2021).","journal-title":"Scand. J. Immunol."},{"key":"86846_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3389\/fimmu.2018.00486","volume":"9","author":"A Kurioka","year":"2018","unstructured":"Kurioka, A. et al. CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells. Front. Immunol. 9, 486 (2018).","journal-title":"Front. Immunol."},{"key":"86846_CR30","doi-asserted-by":"crossref","unstructured":"Lanier, L. L., Chang, C. & Phillips, J. H. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. Journal of immunology (Baltimore, Md.: 1994. 153(6): pp. 2417\u20132428. (1950).","DOI":"10.4049\/jimmunol.153.6.2417"},{"key":"86846_CR31","doi-asserted-by":"publisher","first-page":"1123155","DOI":"10.3389\/fimmu.2023.1123155","volume":"14","author":"M Lenart","year":"2023","unstructured":"Lenart, M. et al. SARS-CoV-2 infection impairs NK cell functions via activation of the LLT1-CD161 axis. Front. Immunol. 14, 1123155 (2023).","journal-title":"Front. Immunol."},{"key":"86846_CR32","doi-asserted-by":"crossref","unstructured":"Kirkham, C. L. & Carlyle, J. R. Complexity and diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition systems. Front. Immunol., 5, 214 (2014).","DOI":"10.3389\/fimmu.2014.00214"},{"key":"86846_CR33","doi-asserted-by":"publisher","first-page":"847576","DOI":"10.3389\/fimmu.2022.847576","volume":"13","author":"VM Braud","year":"2022","unstructured":"Braud, V. M. et al. LLT1-CD161 Interaction in Cancer: promises and challenges. Front. Immunol. 13, 847576 (2022).","journal-title":"Front. Immunol."},{"issue":"9","key":"86846_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s41423-020-0493-9","volume":"17","author":"O Demaria","year":"2020","unstructured":"Demaria, O. et al. Identification of druggable inhibitory immune checkpoints on natural killer cells in COVID-19. Cell Mol. Immunol. 17 (9), 995\u2013997 (2020).","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"86846_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humimm.2021.09.004","volume":"83","author":"M Ghasemzadeh","year":"2022","unstructured":"Ghasemzadeh, M., Ghasemzadeh, A. & Hosseini, E. Exhausted NK cells and cytokine storms in COVID-19: whether NK cell therapy could be a therapeutic choice. Hum. Immunol. 83 (1), 86\u201398 (2022).","journal-title":"Hum. Immunol."},{"issue":"27","key":"86846_CR36","doi-asserted-by":"publisher","first-page":"23823","DOI":"10.1074\/jbc.M110.214254","volume":"286","author":"J Kamishikiryo","year":"2011","unstructured":"Kamishikiryo, J. et al. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A\/KLRB1). J. Biol. Chem. 286 (27), 23823\u201323830 (2011).","journal-title":"J. Biol. Chem."},{"key":"86846_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fimmu.2011.00036","volume":"2","author":"JR Fergusson","year":"2011","unstructured":"Fergusson, J. R., Fleming, V. M. & Klenerman, P. CD161-expressing human T cells. Front. Immunol. 2, 36 (2011).","journal-title":"Front. Immunol."},{"key":"86846_CR38","doi-asserted-by":"crossref","unstructured":"He, X. et al. Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2\u2013inactivated vaccine. Front. Immunol. 14, 1181121 (2023).","DOI":"10.3389\/fimmu.2023.1181121"},{"issue":"1","key":"86846_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41590-021-01095-w","volume":"23","author":"AHE Roukens","year":"2022","unstructured":"Roukens, A. H. E. et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8\u2009+\u2009T cell responses following COVID-19. Nat. Immunol. 23 (1), 23\u201332 (2022).","journal-title":"Nat. Immunol."},{"issue":"1","key":"86846_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12979-022-00269-w","volume":"19","author":"A Karunathilaka","year":"2022","unstructured":"Karunathilaka, A. et al. CD161 expression defines new human \u03b3\u03b4 T cell subsets. Immun. Ageing. 19 (1), 11 (2022).","journal-title":"Immun. Ageing"},{"issue":"1","key":"86846_CR41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1038\/s41467-019-10018-1","volume":"10","author":"KL Truong","year":"2019","unstructured":"Truong, K. L. et al. Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4\u2009+\u2009memory T cells. Nat. Commun. 10 (1), 2263 (2019).","journal-title":"Nat. Commun."},{"issue":"51","key":"86846_CR42","doi-asserted-by":"publisher","first-page":"eabe1670","DOI":"10.1126\/sciimmunol.abe1670","volume":"5","author":"T Parrot","year":"2020","unstructured":"Parrot, T. et al. MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci. Immunol. 5 (51), eabe1670 (2020).","journal-title":"Sci. Immunol."},{"issue":"44","key":"86846_CR43","doi-asserted-by":"publisher","first-page":"37964","DOI":"10.1074\/jbc.M111.285312","volume":"286","author":"C Germain","year":"2011","unstructured":"Germain, C. et al. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-\u03b3 contributes to modulate immune responses. J. Biol. Chem. 286 (44), 37964\u201337975 (2011).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"86846_CR44","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/mi.2016.116","volume":"10","author":"CS McGary","year":"2017","unstructured":"McGary, C. S. et al. The loss of CCR6\u2009+\u2009and CD161\u2009+\u2009CD4\u2009+\u2009T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques. Mucosal Immunol. 10 (4), 1082\u20131096 (2017).","journal-title":"Mucosal Immunol."},{"issue":"1","key":"86846_CR45","doi-asserted-by":"publisher","first-page":"e0084521","DOI":"10.1128\/spectrum.00845-21","volume":"10","author":"W Aljabr","year":"2022","unstructured":"Aljabr, W. et al. Evaluation of the levels of peripheral CD3(+), CD4(+), and CD8(+) T cells and IgG and IgM Antibodies in COVID-19 patients at different stages of infection. Microbiol. Spectr. 10 (1), e0084521 (2022).","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"86846_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23 (2), 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"#cr-split#-86846_CR47.1","unstructured":"Information, N. N. C. B. nCounter\u00aeHuman Immunology V2 panel [NS_Immunology_v2_C2328]. [cited 2024 8 Aug. 2024]"},{"key":"#cr-split#-86846_CR47.2","unstructured":"(2023). Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GPL32993"},{"key":"86846_CR48","doi-asserted-by":"crossref","unstructured":"Amati, F. et al. Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients. Heliyon, 6(10), e05143 (2020).","DOI":"10.1016\/j.heliyon.2020.e05143"},{"issue":"5","key":"86846_CR49","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/biomedicines11051337","volume":"11","author":"A Kuzan","year":"2023","unstructured":"Kuzan, A. et al. What to do if the qPCR test for SARS-CoV-2 or other Pathogen lacks endogenous Internal Control? A simple test on housekeeping genes. Biomedicines 11 (5), 1337 (2023).","journal-title":"Biomedicines"},{"issue":"43","key":"86846_CR50","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"86846_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, 1\u201316 (2004).","journal-title":"Genome Biol."},{"key":"86846_CR52","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv, : p. 060012. (2021)."},{"key":"86846_CR53","doi-asserted-by":"crossref","unstructured":"The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res., 47(D1), D330\u2013D338 (2019).","DOI":"10.1093\/nar\/gky1055"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86846-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86846-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T11:33:18Z","timestamp":1737718398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86846-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86846"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86846-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3079"}}